18
What is the prevalence of CINCA syndrome?
How many people does CINCA syndrome affect? Does it have the same prevalence in men and women? And in the different countries?
The prevalence of CINCA syndrome, also known as neonatal-onset multisystem inflammatory disease (NOMID), is extremely rare. It is estimated to affect approximately 1 in every 1 million individuals worldwide. This chronic autoinflammatory disorder typically manifests in infancy and is characterized by persistent inflammation in multiple organs, including the skin, joints, and central nervous system. Due to its rarity, CINCA syndrome poses significant challenges in diagnosis and treatment. Early recognition and appropriate management are crucial to improve the quality of life for individuals living with this condition.
CINCA syndrome, also known as Chronic Infantile Neurological Cutaneous and Articular syndrome, is an extremely rare autoinflammatory disorder. Due to its rarity, the prevalence of CINCA syndrome is quite low. Exact figures regarding its prevalence are challenging to determine, but it is estimated to affect approximately 1 in every 1,000,000 individuals worldwide.
CINCA syndrome is characterized by a range of symptoms including chronic inflammation of the skin, joints, and nervous system. It typically manifests in early infancy and persists throughout a person's life. The condition can lead to various complications such as growth delays, hearing loss, vision problems, and neurological impairments.
Although CINCA syndrome is a rare disorder, its impact on affected individuals and their families can be significant. Early diagnosis and appropriate management are crucial in improving the quality of life for those living with this condition. Ongoing research and advancements in medical understanding are essential for better understanding the prevalence and treatment options for CINCA syndrome.
Diseasemaps
